SGLT2 Inhibitors Could Play a Role in Treating Gout
A new review considers how SGLT2 inhibitors like dapagliflozin and empagliflozin have been shown to clinically improve gout while reducing its cardiometabolic and renal comorbidities.
Stay updated with breaking news from Published June. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new review considers how SGLT2 inhibitors like dapagliflozin and empagliflozin have been shown to clinically improve gout while reducing its cardiometabolic and renal comorbidities.
Browse the latest in STEM Pathways, including blog articles, Annals research, events, Academy news and more. Content Spotlight Upcoming Events Annals
Dive into the intricate world of malaria, from parasite complexities to climate change, and the latest in vaccination, vital knowledge for health care workers.
Here are the stories that captured your attention in 2023 from NPR.org and across the NPR Network.
Here are the stories that captured your attention in 2023 from NPR.org and across the NPR Network.